Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study

Giorgio Walter Canonica, Gianenrico Senna, Luisa Brussino, Maria Aliani, Elena Altieri, Pietro Bracciale, Maria Filomena Caiaffa, Paolo Cameli, Marco Caminati, Cristiano Caruso, Stefano Centanni, Fausto De Michele, Stefano Del Giacco, Fabiano Di Marco, Laura Malerba, Francesco Menzella, Paola Rogliani, Micaela Romagnoli, Pietro Schino, Jan Walter Schroeder, Alessandra Vultaggio, Maria D'Amato, Girolamo Pelaia

Open source

DOI: 10.1016/j.waojou.2025.101159
Published: 2026-02
Container: World Allergy Organization Journal
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.waojou.2025.101159,
  title = {Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study},
  author = {Giorgio Walter Canonica and Gianenrico Senna and Luisa Brussino and Maria Aliani and Elena Altieri and Pietro Bracciale and Maria Filomena Caiaffa and Paolo Cameli and Marco Caminati and Cristiano Caruso and Stefano Centanni and Fausto De Michele and Stefano Del Giacco and Fabiano Di Marco and Laura Malerba and Francesco Menzella and Paola Rogliani and Micaela Romagnoli and Pietro Schino and Jan Walter Schroeder and Alessandra Vultaggio and Maria D'Amato and Girolamo Pelaia},
  year = {2026},
  journal = {World Allergy Organization Journal},
  doi = {10.1016/j.waojou.2025.101159},
  url = {https://doi.org/10.1016/j.waojou.2025.101159}
}

RIS

TY  - JOUR
TI  - Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study
AU  - Giorgio Walter Canonica
AU  - Gianenrico Senna
AU  - Luisa Brussino
AU  - Maria Aliani
AU  - Elena Altieri
AU  - Pietro Bracciale
AU  - Maria Filomena Caiaffa
AU  - Paolo Cameli
AU  - Marco Caminati
AU  - Cristiano Caruso
AU  - Stefano Centanni
AU  - Fausto De Michele
AU  - Stefano Del Giacco
AU  - Fabiano Di Marco
AU  - Laura Malerba
AU  - Francesco Menzella
AU  - Paola Rogliani
AU  - Micaela Romagnoli
AU  - Pietro Schino
AU  - Jan Walter Schroeder
AU  - Alessandra Vultaggio
AU  - Maria D'Amato
AU  - Girolamo Pelaia
PY  - 2026
JO  - World Allergy Organization Journal
DO  - 10.1016/j.waojou.2025.101159
UR  - https://doi.org/10.1016/j.waojou.2025.101159
ER  -

APA

Canonica, G. W., Senna, G., Brussino, L., Aliani, M., Altieri, E., Bracciale, P., Caiaffa, M. F., Cameli, P., Caminati, M., Caruso, C., Centanni, S., Michele, F. D., Giacco, S. D., Marco, F. D., Malerba, L., Menzella, F., Rogliani, P., Romagnoli, M., Schino, P., Schroeder, J. W., Vultaggio, A., D'Amato, M., & Pelaia, G. (2026). Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study. World Allergy Organization Journal. https://doi.org/10.1016/j.waojou.2025.101159

Source records

crossref · retrieved 2026-09-26T07:20:55.377Z